Delivery Order SPE2DB20D2104-SPE2DB23FV58Q
- Not listed
- This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $1,855.12 firm fixed-price contract is for the supply of VASCEPA 1 GM CAPSULE 120S, a cardiovascular medication. The award has an ultimate completion date of August 30, 2022. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical that serves as a primary vehicle for providing a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,772.26 firm fixed-price delivery order is for the supply of Vascepa 1 GM capsules, a cardiovascular medication. The award has an ultimate completion date of August 25, 2023. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026, which...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of VASCEPA 1 GM CAPSULE 120S, a cardiovascular medication. The $7,777.43 firm fixed-price delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Amerisourcebergen Drug Corp holds with the DLA Troop Support Medical. This IDC serves as the primary vehicle for the company to provide a...
- This federal contract award, valued at $1,261.91, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of VASCEPA 1 GM CAPSULE 120S, a medical product. This award is a Delivery Order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA, valued at $999,999,999 and running through November 2026. The IDC serves as a primary vehicle...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of VASCEPA 1 GM capsules. The contract has a ceiling value of $2,428.08 and a period of performance through November 17, 2023. It is a firm-fixed-price contract, with no set-aside designation. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999, which serves as a primary...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $1,318.76 firm fixed-price delivery order is for the supply of Vascepa 1 GM capsules. The contract has an ultimate completion date of October 18, 2022. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that serves as a critical supplier to various government agencies, particularly the Department of Defense (DoD) and Department of...
- This federal contract award is a delivery order valued at $5,506.26 issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of Vascepa 1 GM capsules and does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which is the prime contractor. This contract is part of a larger $999,999,999 Indefinite Delivery Contract...
- This federal contract award is for the delivery of VASCEPA 1 GM CAPSULE 120S to the Defense Logistics Agency (DLA), a defense agency within the U.S. Department of Defense. The contract, valued at $7,525.73, was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, on February 15, 2023, with a completion date of February 16, 2023. The contract is a Delivery Order and is priced on a Firm Fixed Price basis. The award is not designated as a...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of VASCEPA 1 GM CAPSULE 120S. The contract has a ceiling value of $4,359.73 and a period of performance through June 1, 2023. The contract is a firm-fixed-price delivery order, and there is no set-aside designation, indicating open competition. AmerisourceBergen Drug Corp is a subsidiary of Cencora, Inc., which holds a significant...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a Delivery Order valued at $2,585.69. The contract was awarded by the Defense Logistics Agency (DLA) and is not designated as a set-aside. It covers the supply of ICOSAPENT ETHYL 1 GRAM CAPSULE 120S, a specialty pharmaceutical product. The award is associated with a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, valued at $999,999,999...
- SPE2DB20D2104Indefinite Delivery Contract
- SPE2DB20D2104-SPE2DB23FV58QDelivery Order
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order valued at $3,539.90 with a firm fixed price, and an ultimate completion date of September 29, 2023. The award is for the pharmaceutical product VASCEPA 1 GM CAPSULE 120S. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, which covers similar medical products and prescription drugs. These IDCs enable efficient government procurement of essential pharmaceutical and medical supplies, serving the healthcare needs of military personnel, veterans, and other federal beneficiaries. The contract award reviewed was not designated with any set-aside requirements, indicating open competition.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.5k | 9/28/23 |